Literature DB >> 14762142

KCNQ2 is a nodal K+ channel.

Jérôme J Devaux1, Kleopas A Kleopa, Edward C Cooper, Steven S Scherer.   

Abstract

Mutations in the gene encoding the K+ channel KCNQ2 cause neonatal epilepsy and myokymia, indicating that KCNQ2 regulates the excitability of CNS neurons and motor axons, respectively. We show here that KCNQ2 channels are functional components of axon initial segments and nodes of Ranvier, colocalizing with ankyrin-G and voltage-dependent Na+ channels throughout the CNS and PNS. Retigabine, which opens KCNQ channels, diminishes axonal excitability. Linopirdine, which blocks KCNQ channels, prolongs the repolarization of the action potential in neonatal nerves. The clustering of KCNQ2 at nodes and initial segments lags that of ankyrin-G during development, and both ankyrin-G and KCNQ2 can be coimmunoprecipitated in the brain. KCNQ3 is also a component of some initial segments and nodes in the brain. The diminished activity of mutant KCNQ2 channels accounts for neonatal epilepsy and myokymia; the cellular locus of these effects may be axonal initial segments and nodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762142      PMCID: PMC6793582          DOI: 10.1523/JNEUROSCI.4512-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  Neuronal KCNQ potassium channels: physiology and role in disease.

Authors:  T J Jentsch
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.

Authors:  M S Shapiro; J P Roche; E J Kaftan; H Cruzblanca; K Mackie; B Hille
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  Interaction of the Nav1.2a subunit of the voltage-dependent sodium channel with nodal ankyrinG. In vitro mapping of the interacting domains and association in synaptosomes.

Authors:  Mourad Bouzidi; Nicolas Tricaud; Pierre Giraud; Ekaterini Kordeli; Ghislaine Caillol; Charlotte Deleuze; Francois Couraud; Gisele Alcaraz
Journal:  J Biol Chem       Date:  2002-05-29       Impact factor: 5.157

Review 4.  KCNQ potassium channels: physiology, pathophysiology, and pharmacology.

Authors:  J Robbins
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

5.  Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

Authors:  S L Smart; V Lopantsev; C L Zhang; C A Robbins; H Wang; S Y Chiu; P A Schwartzkroin; A Messing; B L Tempel
Journal:  Neuron       Date:  1998-04       Impact factor: 17.173

6.  Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats.

Authors:  V M Lee; M J Carden; W W Schlaepfer; J Q Trojanowski
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

7.  Expression of tenascin in the developing and adult cerebellar cortex.

Authors:  S Bartsch; U Bartsch; U Dörries; A Faissner; A Weller; P Ekblom; M Schachner
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

8.  Single voltage-dependent potassium channels in rat peripheral nerve membrane.

Authors:  B V Safronov; K Kampe; W Vogel
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.

Authors:  D L Browne; S T Gancher; J G Nutt; E R Brunt; E A Smith; P Kramer; M Litt
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

10.  Evidence for the existence of three types of potassium channels in the frog Ranvier node membrane.

Authors:  J M Dubois
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

View more
  174 in total

1.  M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.

Authors:  Jianli Sun; Jaideep Kapur
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

Review 2.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

Review 3.  Membrane domains based on ankyrin and spectrin associated with cell-cell interactions.

Authors:  Vann Bennett; Jane Healy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08-19       Impact factor: 10.005

4.  The C-terminal domain of ßIV-spectrin is crucial for KCNQ2 aggregation and excitability at nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  J Physiol       Date:  2010-10-20       Impact factor: 5.182

5.  Transcompartmental reversal of single fibre hyperexcitability in juxtaparanodal Kv1.1-deficient vagus nerve axons by activation of nodal KCNQ channels.

Authors:  Edward Glasscock; Jing Qian; Matthew J Kole; Jeffrey L Noebels
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

Review 6.  KCNQ potassium channels in sensory system and neural circuits.

Authors:  Jing-jing Wang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

Review 7.  The Nodes of Ranvier: Molecular Assembly and Maintenance.

Authors:  Matthew N Rasband; Elior Peles
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

8.  Kv7.2 regulates the function of peripheral sensory neurons.

Authors:  Chih H King; Eric Lancaster; Daniela Salomon; Elior Peles; Steven S Scherer
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

Review 9.  Electrogenic tuning of the axon initial segment.

Authors:  Brian D Clark; Ethan M Goldberg; Bernardo Rudy
Journal:  Neuroscientist       Date:  2009-12       Impact factor: 7.519

10.  Activity-dependent transcriptional regulation of M-Type (Kv7) K(+) channels by AKAP79/150-mediated NFAT actions.

Authors:  Jie Zhang; Mark S Shapiro
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.